Portfolio Company · Operating Co.

Attendo

Healthcare

backed byBridgepoint Group

CurrentHealthcare

Attendo

a portfolio company of

Bridgepoint Group

Status on record: Current

PE Firm Index

Who owns Attendo?

Attendo is listed as a current portfolio company of Bridgepoint Group on Bridgepoint Group's own portfolio page.

Company Snapshot

Attendo is a Healthcare company. Its owner on record, Bridgepoint Group, is a private equity firm founded in 1984, headquartered in London, England, with £38.8 billion under management. Bridgepoint Group lists 176 companies in the index, 11 of them in Healthcare.

SectorHealthcare

Parent PE firmBridgepoint Group

Ownership statusCurrent

WebsiteNot on record

About the owner

Bridgepoint Group

Headquarters: London, England
Founded: 1984
AUM: £38.8 billion
Strategy: Private Equity, Buyout
Target size: Middle-market (e.g., deals valued between £250M and £800M+)
Sectors: Consumer, Healthcare
Companies in the index: 176

Bridgepoint Group is a British private investment company that specializes in private equity and credit, listed on the London Stock Exchange.

Read the Bridgepoint Group profile

Questions about Attendo

Who owns Attendo?

Attendo is listed as a current portfolio company of Bridgepoint Group on Bridgepoint Group's own portfolio page.

What sector is Attendo in?

Attendo is in Healthcare. Classified from the owner's portfolio label.

Where is Bridgepoint Group headquartered?

Bridgepoint Group is headquartered in London, England.

What else does Bridgepoint Group own in Healthcare?

Bridgepoint Group lists 10 other Healthcare companies in the index, including Aenova, Altano Group, Avalere Health (formerly Fishawack), Axplora and Balt.

Sources

Bridgepoint Group
https://www.bridgepointgroup.com/investment-strategies/private-equity/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Attendo and does not provide investment advice.

Other portfolio companies of Bridgepoint Group

6 of 175 shown

A-Katsastus

Business and Financial Services

Abion (formerly Ports Group)

Technology

Achilles

Business and Financial Services

ACT

Business and Financial Services

See the full Bridgepoint Group portfolio.

Other Healthcare companies held by Bridgepoint Group

Acteon Aenova Altano Group Avalere Health (formerly Fishawack)Axplora Balt

Other Healthcare portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Bridgepoint Group

London, England

Status: Current

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.